Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berger

Showing results (651-660 of 774) with videos related to

Pageof 78
Sort By:
Circulation. Cardiovascular Interventions|July 25, 2013
Prognostic value of access and non-access sites bleeding after percutaneous coronary interventionGjin Ndrepepa, Franz-Josef Neumann, Gert Richardt, et al.
The British Journal of Ophthalmology|March 1, 1997
Management of varicella zoster virus retinitis in AIDSR S Moorthy, D V Weinberg, S A Teich, et al.
JACC. Cardiovascular Interventions|March 10, 2018
2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness RatingsEdward L Hannan, Zaza Samadashvili, Kimberly Cozzens, et al.
Journal of the American College of Cardiology|October 3, 2003
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)Albert W Chan, David J Moliterno, Peter B Berger, et al.
Circulation|August 2, 2000
Application of the New York State PTCA mortality model in patients undergoing stent implantationD R Holmes, P B Berger, K N Garratt, et al.
JACC. Cardiovascular Interventions|February 11, 2017
The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public ReportingEdward L Hannan, Ye Zhong, Kimberly Cozzens, et al.
American Journal of Ophthalmology|December 15, 1988
Ocular toxoplasmosis in patients with the acquired immunodeficiency syndromeG N Holland, R E Engstrom, B J Glasgow, et al.
Circulation|April 1, 1995
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II InvestigatorsD R Holmes, E J Topol, R M Califf, et al.
Journal of Electrocardiology|February 13, 2007
Paramedic transtelephonic communication to cardiologist of clinical and electrocardiographic assessment for rapid reperfusion of ST-elevation myocardial infarctionDavid G Strauss, Paula Quintal Sprague, Kevin Underhill, et al.
Circulation|October 25, 2006
Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventionsGjin Ndrepepa, Adnan Kastrati, Julinda Mehilli, et al.
Pageof 78

Showing results (651-660 of 774) with videos related to

Sort By:
Pageof 78
Circulation. Cardiovascular Interventions|July 25, 2013
Prognostic value of access and non-access sites bleeding after percutaneous coronary interventionGjin Ndrepepa, Franz-Josef Neumann, Gert Richardt, et al.
The British Journal of Ophthalmology|March 1, 1997
Management of varicella zoster virus retinitis in AIDSR S Moorthy, D V Weinberg, S A Teich, et al.
JACC. Cardiovascular Interventions|March 10, 2018
2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness RatingsEdward L Hannan, Zaza Samadashvili, Kimberly Cozzens, et al.
Journal of the American College of Cardiology|October 3, 2003
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)Albert W Chan, David J Moliterno, Peter B Berger, et al.
Circulation|August 2, 2000
Application of the New York State PTCA mortality model in patients undergoing stent implantationD R Holmes, P B Berger, K N Garratt, et al.
JACC. Cardiovascular Interventions|February 11, 2017
The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public ReportingEdward L Hannan, Ye Zhong, Kimberly Cozzens, et al.
American Journal of Ophthalmology|December 15, 1988
Ocular toxoplasmosis in patients with the acquired immunodeficiency syndromeG N Holland, R E Engstrom, B J Glasgow, et al.
Circulation|April 1, 1995
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II InvestigatorsD R Holmes, E J Topol, R M Califf, et al.
Journal of Electrocardiology|February 13, 2007
Paramedic transtelephonic communication to cardiologist of clinical and electrocardiographic assessment for rapid reperfusion of ST-elevation myocardial infarctionDavid G Strauss, Paula Quintal Sprague, Kevin Underhill, et al.
Circulation|October 25, 2006
Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventionsGjin Ndrepepa, Adnan Kastrati, Julinda Mehilli, et al.
Pageof 78